May 15, 2012, 03.50 PM IST
AstraZeneca Mar '12 sales at Rs 91.79 crore
AstraZeneca Pharma has reported a sales turnover of Rs 91.79 crore and a net loss of Rs 33.00 crore for the quarter ended Mar '12
Like this story, share it with millions of investors on M3
AstraZeneca Mar '12 sales at Rs 91.79 crore
AstraZeneca Pharma has reported a sales turnover of Rs 91.79 crore and a net loss of Rs 33.00 crore for the quarter ended Mar '12
Like this story, share it with millions of investors on M3
AstraZeneca Mar '12 sales at Rs 91.79 crore
AstraZeneca Pharma has reported a sales turnover of Rs 91.79 crore and a net loss of Rs 33.00 crore for the quarter ended Mar '12
Share . Email . Print . A+A-
AstraZeneca Pharma has reported a sales turnover of Rs 91.79 crore and a net loss of Rs 33.00 crore for the quarter ended Mar '12.
| For the quarter ended Mar 2011 the sales turnover was Rs 126.68 crore and net profit was Rs 8.35 crore.
|
| | | Quarterly Results of AstraZeneca Pharma | -------- in Rs. Cr. -------- |
| | Mar '11 | | | Dec '11 | Mar '12 | | Sales Turnover | 126.68 | | | 153.48 | 91.79 | | Other Income | 2.20 | | | 1.50 | 2.01 | | Total Income | 128.88 | | | 154.99 | 93.80 | | Total Expenses | 110.08 | | | 131.10 | 140.95 | | Operating Profit | 16.60 | | | 22.38 | -49.16 | | Profit On Sale Of Assets | -- | | | -- | -- | | Profit On Sale Of Investments | -- | | | -- | -- | | Gain/Loss On Foreign Exchange | -- | | | -- | -- | | VRS Adjustment | -- | | | -- | -- | | Other Extraordinary Income/Expenses | -- | | | -- | -- | | Total Extraordinary Income/Expenses | -- | | | -- | -- | | Tax On Extraordinary Items | -- | | | -- | -- | | Net Extra Ordinary Income/Expenses | -- | | | -- | -- | | Gross Profit | 18.80 | | | 23.88 | -47.15 | | Interest | -- | | | -- | -- | | PBDT | 18.80 | | | 23.89 | -47.14 | | Depreciation | 1.76 | | | 1.89 | 1.81 | | Depreciation On Revaluation Of Assets | -- | | | -- | -- | | PBT | 17.04 | | | 22.00 | -48.95 | | Tax | 8.69 | | | 7.06 | -15.95 | | Net Profit | 8.35 | | | 14.94 | -33.00 | | Prior Years Income/Expenses | -- | | | -- | -- | | Depreciation for Previous Years Written Back/ Provided | -- | | | -- | -- | | Dividend | -- | | | -- | -- | | Dividend Tax | -- | | | -- | -- | | Dividend (%) | -- | | | -- | -- | | Earnings Per Share | 3.34 | | | 5.97 | -- | | Book Value | -- | | | -- | -- | | Equity | 5.00 | | | 5.00 | 5.00 | | Reserves | -- | | | -- | -- | | Face Value | 2.00 | | | 2.00 | 2.00 | | Source : Dion Global Solutions Limited |
|
|
From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'
The latest earning numbers FIRST on CNBC-TV18
|
